The strengths of this study include the dynamic analysis of IgG and IgM antibody levels, viral nucleic acid CT values at admission, and levels of T lymphocyte subsets to assess the risks of re-positivity among patients infected with the Delta variant infection, understand the re-positivity rate of Delta variant infection. This evidence concerns the gene CD40LG and infection.